Advertisement

Topics

Companies Related to "Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)" [Most Relevant Company Matches] - Page: 5 RSS

03:06 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)" found in our extensive corporate database of over 50,000 company records.

Showing "Study BuEAM Conditioning Autologous Stem Cell Transplantation ASCT" Companies 101–125 of 2,100+

Relevant

Shenzhen Beike Biotechnology Co. Ltd.

Beike Biotechnology ( http://www.beikebiotech.com ) is China's leading biotechnology company. Its scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's unique processing technologies prepare the cells for ...


Angiocrine Bioscience, Inc.

Angiocrine Bioscience is a privately held biotech company focused on applying vascular biology to new therapeutic applications. Angiocrine’s VeraVecTM technology platform is based on endothelial cells that have been genetically modified such that they can be rapidly and durably expanded in culture. Because these cells secrete and display factors essential ...

Bio-Matrix Scientific Group Inc.

Bio-Matrix Scientific Group Inc. (OTCBB: BMSN) is a biotech research and development company that commercializes medical devices and monitoring systems for the growing worldwide stem cell research market. Its new 15,000 square foot facility houses two secure cryogenic stem cell banks, three research laboratories, aseptic cellular/tissue class 10,000/100 processing lab, hematology, microbiology an...


Genea Stem Cells Pty Ltd

Genea Biocells Pty Ltd is a subsidiary of Genea Limited (formerly Sydney IVF Limited), a public, unlisted company that has been operating IVF clinics in Australia since 1985. Genea Biocells Pty Ltd is governed by the same strong ethical principles and corporate governance practices. Genea Biocells is located in Sydney, Australia and has been supplying commercial stem cell solutions for several...

OncoMed Pharmaceuticals, Inc.

OncoMed is a clinical development-stage biopharmaceutical company focused on discovering and developing first-in-class monoclonal antibody therapeutics targeting cancer stem cells, or CSCs. Our approach has been to target CSCs, which are the subpopulation of cells in a tumor responsible for driving growth and metastasis of the tumor. CSCs, also known as tumor-initiating cells, exhibit certain pr...

Verastem, Inc. Verastem, Inc.

Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK, PI3K/mTOR a...

MEDINET Co., Ltd. and MaxCyte, Inc.

MEDINET is a world leading company in cell therapy, supporting medical service providers in Japan. Through its service, MEDINET provides medical institutions with advanced technologies and knowhow in: cell processing and culturing, quality control, and facility management with respect to the immuno-cell therapy. MEDINET has extensive experience in autologo...

Progentix BV

Progentix’ cutting edge technology will allow for a totally new approach to the regeneration of diseased or damaged tissues. It will enable surgeons to repair bone, cartilage and heart muscle in a everyday hospital setting by using Progentix' unique stand-alone, simple-to-operate bioreactor system.Progentix has designed its advanced bioreactor system to bring the clinical application of expanded...

BioTime, Inc. and Abcodia Ltd.

BioTime is a biotechnology company engaged in research and product development in the field of regenerative medicine. Regenerative medicine refers to therapies based on stem cell technology that are designed to rebuild cell and tissue function lost due to degenerative disease or injury. BioTime’s focus is on pluripotent stem cell technology based on h...

Stemline Therapeutics, Inc.

Stemline Therapeutics, Inc. is a clinical stage biotechnology company developing novel oncology compounds directed to cancer stem cell targets. Stemline's lead compound, SL-401, targets the interleukin-3 receptor which is expressed on multiple hematological cancers including leukemia blasts and leukemia cancer stem cells. SL-401 has demonstrated single agent anti-tumor activity at tolerable doses ...

Klinik für Knochenmarktransplantation und Hämatologie / Onkologie GmbH

Our center is specialized in state-of-the-art diagnosis and treatment for hematology / oncology diseases and bone marrow/stem cell transplantation for adults and children.It was founded in 1994 by the Stefan-Morsch-Foundation. The first bone marrow donor registry in Germany was established in 1986. Since 1997, our center is affiliated to "Saarland Heilstaetten Group" (SHG) which operates several h...

Minerva Biotechnologies

Minerva Biotechnologies is a pioneer in the field of stem cells and cancer stem cells. Minerva was first to discover that cancer cells hijack an otherwise normal stem cell growth mechanism, involving a growth factor receptor called MUC1* (pronounced muk 1 star). By studying human stem cells in parallel with human cancer cells, Minerva scientists figured ou...

NuGene International, Inc.

NuGene International, Inc. specializes in developing, manufacturing and marketing proprietary regenerative cosmeceutical and pharmaceutical products based on adipose derived human stem cell and human stem cell media. The US Department of Health and Human Services calls regenerative medicine the "next evolution of medical treatments." The regenerative medic...

Creative Medical Health, Inc.

CREATIVE MEDICAL HEALTH, INC. and its wholly owned subsidiaries, in collaboration with leading U.S. universities, physicians and scientists, have developed and tested our patented cutting-edge BIONUTRACEUTICAL(TM) products, stem cell related blood testing services and treatment of various medical conditions with stem cell technology. Our area of concentrat...

The Stem Cell Institute

Stem Cell Innovations, Inc.

Stem Cell Summit

Stem Cell Biotherapy

Stem Cell Network

VistaGen Therapeutics, Inc.

VistaGen Therapeutics is a biotechnology company focused on using proprietary pluripotent stem cell technology to discover, rescue and develop novel drug candidates for a broad range of diseases and conditions. VistaGen’s integrated stem cell technology platform, Human Clinical Trials in a Test Tube™, is based on the differentiation of human plur...

Brainstorm Cell Therapeutics

BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to treat diseases such as Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) and Multiple Sclerosis (MS). The adu...

Kiadis Pharma N.V.

Kiadis Pharma is a clinical stage biopharmaceutical company focused on research, development and future commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The Company believes that its innovative products have the potential to address the current risks and limitations connected with allo...

Iterion Therapeutics

Iterion Therapeutics is a venture-backed, clinical stage biotechnology company developing novel targeted cancer therapeutics. The company’s lead product, Tegavivint, is a potent and selective inhibitor of the Wnt/b-catenin signaling pathway, implicated in cell proliferation, differentiation, immune evasion and stem cell renewal. Tegavivint demonstrate...

LifeMap Sciences, Inc.

LifeMap Sciences’ (www.lifemapsc.com) core technology and business is based on its integrated database suite, the discovery platform for biomedical and stem cell research. This platform includes GeneCards®, the leading human gene database; LifeMap Discovery™, the database of embryonic development, stem cell research and regenerative medicine; ...

StemCellSciences UK Ltd

Stem Cell Sciences is an international company with centres in the United Kingdom,Australia and Japan. It has been active in the stem cell research field since 1994, principally focused on technologies to grow, differentiate, select and purify embryonic stem cells. The company now has a substantial portfolio of patents and patent applications within these areas. These include technologies to permi...


More From BioPortfolio on "Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks